Cognitive Function Assessment for Dementia and MCI

Dementia and Mild Cognitive Impairment: Assessment of Cognitive Functioning, Functional Autonomy, and Neuropsychiatric Symptoms.

Recruiting Observational Study
Dementia Mild Cognitive Impairment (MCI)
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 86
Sex
Any
Study type
Observational
Participants needed
151 (estimated)
Sponsor
IRCCS Centro Neurolesi Bonino Pulejo · Other
Who this trial is looking for

This trial is looking for adults aged 50 to 86 who may have dementia or mild cognitive impairment (MCI). Participants will undergo assessments to understand their cognitive abilities and daily functioning.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 50 and 86 years old.
  • I have a suspected or confirmed diagnosis of dementia or MCI.
  • I am referred to the neuropsychology clinic for assessment.
  • I do not have severe behavioral or psychiatric disorders.

You may not be able to join if

  • I have a neurological disorder other than dementia or MCI.
  • I have unstable major psychiatric issues right now.
  • I have uncorrected severe vision or hearing problems.
  • I am taking medications that significantly affect cognition.
  • I have serious medical or cancer conditions that interfere with assessments.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Dementia, in its various forms, is characterized by a generalized cognitive decline that can significantly compromise personal autonomy and quality of life. Mild Cognitive Impairment (MCI), although not classified as an overt form of dementia, represents a condition at evolutionary risk and is considered a crucial transitional stage for the early detection of cognitive decline. Understanding the i…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age between 50 and 86 years. * Suspected or confirmed diagnosis of dementia or mild cognitive impairment (MCI). * Referral to the neuropsychology clinic for initial assessment or clinical monitoring. * Absence of behavioral, psychiatric, or sensory disorders severe enough to s…
Contacts

Francesco Corallo

09060128335

francesco.corallo@irccsme.it

CONTACT